Genzyme CEO David Meeker being interviewed by Alison Taunton-Rigby, a long-time Boston biotech CEO (and former Genzyme executive.)
Julian Adams of Infinity Pharmaceuticals, Philip Vickers of Shire, and Bruce Booth of Atlas Venture talk about how drug R&D is changing.
OvaScience CEO and Longwood Fund co-founder Michelle Dipp being interviewed by Michelle Browner, CEO of Enlight Biosciences.
Third Rock Ventures founder Mark Levin with Katrine Bosley, former CEO at Avila Therapeutics.
Participants relax on the lawn of the Wequassett Inn.
About Scott Kirsner
Scott Kirsner was part of the team that launched Boston.com in 1995, and has been writing a column for the Globe since 2000. His work has also appeared in Wired, Fast Company, The New York Times, BusinessWeek, Newsweek, and Variety. Scott is also the author of the books "Fans, Friends & Followers" and "Inventing the Movies," was the editor of "The Convergence Guide: Life Sciences in New England," and was a contributor to "The Good City: Writers Explore 21st Century Boston." Scott also helps organize several local events on entrepreneurship, including the Nantucket Conference and Future Forward. Here's some background on how Scott decides what to cover, and how to pitch him a story idea.
Subscribe via e-mail
More from Scott
March 3: Web Innovators Group
Demos, drinks, and schmoozing at the Royal Sonesta in Cambridge.
March 7-8: MassDigi Game Challenge
Competition for aspiring game developers... plus panels and keynotes related to the business of play.
April 3-4: Mass Biotech Annual Meeting
Issues facing the region's life sciences community.